Who owns Evogene Ltd shs?
- CUSIP Number: m4119s104
Tip: Access positions for across all investors
Analyze quarterly positions in Evogene with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Evogene stock
Who bought or sold Evogene Ltd shs this quarter?
There are no current stakeholders of Evogene.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Evogene?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Bnp Paribas Arbitrage, Snc | Jun 2024 | 100k | $65k |
LPL Financial | Jun 2024 | 67k | $44k |
Susquehanna International | Jun 2024 | 61k | $40k |
Geode Capital Management | Jun 2024 | 59k | $38k |
Renaissance Technologies | Jun 2024 | 45k | $29k |
Pnc Financial Services | Jun 2024 | 38k | $25k |
Citadel Advisors | Jun 2024 | 24k | $16k |
Sigma Planning | Jun 2024 | 23k | $15k |
Csenge Advisory Group | Jun 2024 | 21k | $14k |
XTX Topco | Jun 2024 | 15k | $9.9k |
Jpmorgan Chase & Co | Jun 2024 | 15k | $9.7k |
Private Advisor | Jun 2024 | 14k | $9.1k |
Susquehanna International Group | Jun 2024 | 13k | $8.7k |
Bank of America Corporation | Jun 2024 | 6.4k | $4.2k |
Federation des caisses Desjardins du Quebec | Jun 2024 | 5.0k | $3.3k |
Simplex Trading | Jun 2024 | 1.2k | $0 |
Royal Bank of Canada | Jun 2024 | 461.00 | $0 |
Cypress Capital | Jun 2024 | 400.00 | $260.000000 |